SEC Form 4 · accession 0001179110-16-025476
Theravance Biopharma, Inc. · TBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Junning Lee
Officer — Sr. VP, Technical Operations
Period of report
May 20, 2016
Accepted (ET)
May 24, 2016 · 7:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | May 20, 2016 | F | 3,785 | $20.55 | D | 242,252 | D | |
| Ordinary SharesF2 | holding | — | — | — | 9,000 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 1,702 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 13, 2016.
- F2By Spouse as holder of self directed retirement account. Reporting person disclaims beneficial ownership of these securities in excess of his pecuniary interest therein.